2026 Biotech & Life Sciences Financing Landscape

How growth-stage biotech and deep-tech companies are positioning for institutional capital across venture crossover, strategic capital, and project finance.

Download PDF

20-page PDF · Sector Primer

Scientist working in a biotechnology laboratory

This sector primer outlines financing pathways for biotech and life sciences companies at growth stage, including considerations for government co-funding, strategic partnerships, and cross-border SPV structures.

Key themes

Investor diligence shifting toward commercialization timelines and offtake credibility
Strategic capital playing a larger role alongside traditional growth equity
Project-level financing gaining traction for capital-intensive scale-up assets
Narrative and data-room quality as decisive factors in competitive raises

Methodology

Compiled from sector mandates, investor feedback, and public market comparables as of Q1 2026. For informational purposes only.

← Back to Reports